Diadexus Inc is categorized under In Vitro Diagnostics in South San Francisco, CA and active since 1995.
Diadexus Inc was established in 1995, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a In Vitro Diagnostics business, which does work in the B2B market, and is classified as a In Vitro Diagnostics, under code number 325413 by the NAICS.
If you are seeking more information, feel free to contact Brian E Ward at the company’s headquarters by writing to 349 Oyster Point Boulevard # 201, South San Francisco, California CA 94080 or by phoning (650) 246-6400. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Diadexus Inc |
| Contact Person: | Brian E Ward |
| Address: | 349 Oyster Point Boulevard # 201, South San Francisco, California 94080 |
| Phone Number: | (650) 246-6400 |
| Website Address: | diadexus.com |
| Annual Revenue (USD): | $20.000.000 to $49.9999.999 |
| Founded: | 1995 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | In Vitro Diagnostics |
| SIC Code: | 2835 |
| NAICS Code: | 325413 |
| Share This Business: |
Diadexus Inc was started in 1995 to provide professional In Vitro Diagnostics under the SIC code 2835 and NAICS code 325413. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.
Feel free to contact Brian E Ward for inquiries that concern Diadexus Inc by calling the company number (650) 246-6400, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Diadexus Inc can be found at the coordinates 37.663448,-122.384959 as well as the street address 349 Oyster Point Boulevard # 201 in South San Francisco, California 94080.
For its online presence, you may visit Diadexus Inc’s website at diadexus.com and engage with its social media outlets through on Twitter and on Facebook.